0

Journal Articles

in Cardiac Biomarkers
 81-100 of 190 Articles
JAMA Internal Medicine | 
Editor's Correspondence |  July 23, 2007
C-Reactive Protein Is Still a Potential Aid in Rheumatoid Arthritis Predictors
Jerome Tanzer, MD
Arch Intern Med. 2007;167(14):1552. doi:10.1001/archinte.167.14.1552-a.
JAMA Internal Medicine | 
Editor's Correspondence |  July 23, 2007
C-Reactive Protein Is Still a Potential Aid in Rheumatoid Arthritis Predictors—Reply
Nancy A. Shadick, MD, MPH; Elizabeth W. Karlson, MD; I-Min Lee, MBBS, ScD
Arch Intern Med. 2007;167(14):1552. doi:10.1001/archinte.167.14.1552-b.
JAMA Internal Medicine | 
Original Investigation |  March 12, 2007 FREE
Effect of a High-Fiber Diet vs a Fiber-Supplemented Diet on C-Reactive Protein Level
Dana E. King, MD, MS; Brent M. Egan, MD; Robert F. Woolson, PhD; et al.
Arch Intern Med. 2007;167(5):502-506. doi:10.1001/archinte.167.5.502.
JAMA Ophthalmology | 
Epidemiology |  March 01, 2007 FREE
High-Sensitivity C-Reactive Protein, Other Markers of Inflammation, and the Incidence of Macular Degeneration in Women
Debra A. Schaumberg, ScD, OD, MPH; William G. Christen, ScD; Julie E. Buring, ScD; et al.
Arch Ophthalmol. 2007;125(3):300-305. doi:10.1001/archopht.125.3.300.
INCLUDES: CME
JAMA Surgery | 
Original Article |  February 01, 2007 FREE
Evaluation of Procalcitonin for Predicting Septic Multiorgan Failure and Overall Prognosis in Secondary Peritonitis:  A Prospective, International Multicenter Study
Bettina M. Rau, MD; Isabella Frigerio, MD; Markus W. Büchler, MD; et al.
Arch Surg. 2007;142(2):134-142. doi:10.1001/archsurg.142.2.134.
JAMA Neurology | 
Original Contribution |  February 01, 2007 FREE
Apolipoprotein E Gene Polymorphism, Total Plasma Cholesterol Level, and Parkinson Disease Dementia
Barbara Jasinska-Myga, MD, PhD; Grzegorz Opala, MD, PhD; Christopher G. Goetz, MD; et al.
Arch Neurol. 2007;64(2):261-265. doi:10.1001/archneur.64.2.261.
JAMA Internal Medicine | 
Review Article |  January 08, 2007 FREE
The Effect of Weight Loss on C-Reactive Protein:  A Systematic Review
Elizabeth Selvin, PhD, MPH; Nina P. Paynter, MHS; Thomas P. Erlinger, MD, MPH
Arch Intern Med. 2007;167(1):31-39. doi:10.1001/archinte.167.1.31.
JAMA | 
Original Contribution |  December 13, 2006 FREE
Association of Polymorphisms in the CRP Gene With Circulating C-Reactive Protein Levels and Cardiovascular Events
Leslie A. Lange, PhD; Christopher S. Carlson, PhD; Lucia A. Hindorff, PhD; et al.
JAMA. 2006;296(22):2703-2711. doi:10.1001/jama.296.22.2703.
JAMA Internal Medicine | 
Editorial |  December 11, 2006
The Latest and Greatest New Biomarkers:  Which Ones Should We Measure for Risk Prediction in Our Practice?
James A. de Lemos, MD
Arch Intern Med. 2006;166(22):2428-2430. doi:10.1001/archinte.166.22.2428.
JAMA Internal Medicine | 
Original Investigation |  December 11, 2006 FREE
High-Sensitivity C-Reactive Protein and Risk of Nontraumatic Fractures in the Bruneck Study
Georg Schett, MD; Stefan Kiechl, MD; Siegfried Weger, MD; et al.
Arch Intern Med. 2006;166(22):2495-2501. doi:10.1001/archinte.166.22.2495.
JAMA Internal Medicine | 
Original Investigation |  December 11, 2006 FREE
C-Reactive Protein in the Prediction of Rheumatoid Arthritis in Women
Nancy A. Shadick, MD, MPH; Nancy R. Cook, ScD; Elizabeth W. Karlson, MD; et al.
Arch Intern Med. 2006;166(22):2490-2494. doi:10.1001/archinte.166.22.2490.
JAMA Internal Medicine | 
Original Investigation |  December 11, 2006 FREE
Comparison of N-Terminal Pro–B-Natriuretic Peptide, C-Reactive Protein, and Creatinine Clearance for Prognosis in Patients With Known Coronary Heart Disease
Dietrich Rothenbacher, MD, MPH; Wolfgang Koenig, MD; Hermann Brenner, MD, MPH
Arch Intern Med. 2006;166(22):2455-2460. doi:10.1001/archinte.166.22.2455.
INCLUDES: CME
JAMA Internal Medicine | 
Review Article |  December 11, 2006 FREE
Elevated Cardiac Troponin Measurements in Critically Ill Patients
Wendy Lim, MD, MSc(Epid); Ismael Qushmaq, MD; P. J. Devereaux, MD, PhD(Epid); et al.
Arch Intern Med. 2006;166(22):2446-2454. doi:10.1001/archinte.166.22.2446.
JAMA Internal Medicine | 
Original Investigation |  October 23, 2006 FREE
High-Sensitivity C-Reactive Protein, Lipoprotein-Associated Phospholipase A2, and Outcome After Ischemic Stroke
Mitchell S. V. Elkind, MD, MS; Wanling Tai, BS; Kristen Coates, BS; et al.
Arch Intern Med. 2006;166(19):2073-2080. doi:10.1001/archinte.166.19.2073.
INCLUDES: CME
JAMA Internal Medicine | 
Editor's Correspondence |  July 24, 2006
C-Reactive Protein Is an Intermediate Step Between Obesity and Hypertension
Ana Azevedo, MD; Henrique Barros, MD, PhD
Arch Intern Med. 2006;166(14):1526-1527. doi:10.1001/archinte.166.14.1526-b.
JAMA Internal Medicine | 
Editor's Correspondence |  July 24, 2006
C-Reactive Protein Is an Intermediate Step Between Obesity and Hypertension—Reply
Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; et al.
Arch Intern Med. 2006;166(14):1527. doi:10.1001/archinte.166.14.1527-a.
JAMA Internal Medicine | 
Original Investigation |  July 10, 2006 FREE
An Assessment of Incremental Coronary Risk Prediction Using C-Reactive Protein and Other Novel Risk Markers:  The Atherosclerosis Risk in Communities Study
Aaron R. Folsom, MD, MPH; Lloyd E. Chambless, PhD; Christie M. Ballantyne, MD; et al.
Arch Intern Med. 2006;166(13):1368-1373. doi:10.1001/archinte.166.13.1368.
INCLUDES: CME
JAMA Internal Medicine | 
Editor's Correspondence |  June 26, 2006
C-Reactive Protein and Cardiovascular Risk in the Framingham Study
Paul Ridker, MD; Nader Rifai, PhD; Wolfgang Koenig, MD; et al.
Arch Intern Med. 2006;166(12):1327-1328. doi:10.1001/archinte.166.12.1327-b.
JAMA Internal Medicine | 
Editor's Correspondence |  June 26, 2006
C-Reactive Protein and Cardiovascular Risk in the Framingham Study—Reply
Peter W. F. Wilson, MD; Michael Pencina, PhD; Ralph B. D’Agostino, PhD; et al.
Arch Intern Med. 2006;166(12):1327-1328. doi:10.1001/archinte.166.12.1328.
JAMA Internal Medicine | 
Editor's Correspondence |  May 08, 2006
The Role of Inflammation for Heart Disease Risk Cannot Be Determined by Correlations Between C-Reactive Protein and Risk Factors
Gunnar Engström, MD, PhD
Arch Intern Med. 2006;166(9):1040-1041. doi:10.1001/archinte.166.9.1040-a.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Grand Rounds  |  June 05, 2013
Increasingly Sensitive Assays for Cardiac Troponins:  A Review
James A. de Lemos, MD
JAMA Internal Medicine
Challenges in Clinical Electrocardiography  |  March 11, 2013
Finding Needles in a Haystack—Diagnosis
JAMA Internal Medicine
Original Investigation  |  April 8, 2013
High-Sensitivity Cardiac Troponin T Levels and Secondary Events in Outpatients With Coronary Heart Disease From the Heart and Soul Study
Alexis L. Beatty, MD; Ivy A. Ku, MD, MAS; Robert H. Christenson, PhD; et al.
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Routine Noninvasive Testing and Highly Sensitive Troponin Immunoassays
Giuseppe Lippi, MD; Gianfranco Cervellin, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems